Skip to content

Spinal Muscular Atrophy I Cn381124

Published: July 22, 2026Updated: August 20, 2026

A genetic neuromuscular disorder causing severe muscle weakness and loss of motor neurons from infancy. Infants have trouble breathing, swallowing, and moving. Historically fatal in early childhood, though newer therapies are changing outcomes.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 20, 2026Editorial policy

Key facts at a glance

ICD-10
G40.909
ICD-11
8A00.0
Body system
neurologic
Severity
fatal
Chronic
true

Signs and symptoms

Common signs and symptoms that may indicate this condition.

Warning signs - seek immediate care

!

Generalized symptoms

Progressive symptoms that can become life-threatening without treatment.

Seek immediate medical attention if symptoms worsen.

!

Respiratory insufficiency requiring ventilatory support

!

Feeding difficulties due to bulbar weakness

Profound hypotonia

(neurologic)

Absent deep tendon reflexes

(neurologic)

Diagnosis and tests

How this condition is diagnosed and what test results mean.

Initial screening tests

1

Standard diagnostic workup

Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]

Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]

Treatment options

Evidence-based approaches to managing this condition.

First-line treatments

1

Disease-modifying pharmacotherapy

Specialized medications that target the underlying genetic cause to increase survival motor neuron protein production. Treatment typically initiated as early as possible for best outcomes.

medication
2

Standard interventional procedure protocol

Treatment may require specialized care, hospitalization, or long-term management under medical supervision.

procedure
3

Respiratory function monitoring

Regular assessment of respiratory capacity including vital capacity measurements and blood gas analysis. Early identification of respiratory decline allows for timely intervention.

monitoring

Additional treatment options

Chest physiotherapy and respiratory support

Techniques to maintain chest wall mobility, assist with secretion clearance, and support breathing function. Includes positioning and manual techniques.

physical_therapy

Nutritional support and feeding assessment

Evaluation of nutritional status and feeding abilities with consideration for swallowing difficulties. May include modified textures or supplemental feeding approaches.

dietary

Respiratory support device management

Non-invasive ventilation support to assist with breathing, typically initiated when respiratory function declines. Equipment selection and settings individualized.

surgical

When to seek medical help

Recognize when you need immediate medical attention.

Call emergency services (911) immediately

!

Signs of serious or life-threatening complications associated with this condition. Immediate medical evaluation is required.

Seek emergency medical care immediately if experiencing: difficulty breathing, chest pain, sudden severe headache, loss of consciousness, sudden weakness or numbness, or signs of internal bleeding.

Frequently asked questions

Common questions about this topic.

Q

What is Spinal Muscular Atrophy I Cn381124?

Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]

general

Sources and references

Authoritative medical sources used to create this content.

1

Mercuri E, Finkel RS, Muntoni F, et al. Diagnosis and management of spinal muscular atrophy: part 1. Neuromuscul Disord. 2018.

guideline2018
2

Finkel RS, Mercuri E, Darras BT, et al. Nusinersen versus sham control in infantile-onset spinal muscular atrophy. N Engl J Med. 2017.

clinical_trial2017
3

Kolb SJ, Kissel JT. Spinal muscular atrophy: a timely review. Arch Neurol. 2011.

review2011
4

Schoenmakers D, Scheepers H, Bhatt S, et al. Gene replacement therapy for spinal muscular atrophy: a systematic review and meta-analysis. Lancet Neurol. 2023.

meta_analysis2023

Medication Comparisons

Compare medications used to treat Spinal Muscular Atrophy I Cn381124. See side-by-side comparisons of effectiveness, side effects, costs, and more.

View Medication Comparisons

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy